Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical (Oncology: GU)

  • You have access
    Feasibility of 99mTc-MIP-1404 for SPECT/CT imaging and subsequent PSMA-radioguided surgery in early biochemical recurrent prostate cancer: a case series of 9 patients
    Daniel Koehler, Markus Sauer, Susanne Klutmann, Ivayla Apostolova, Wencke Lehnert, Lars Budäus, Sophie Knipper and Tobias Maurer
    Journal of Nuclear Medicine July 14, 2022, jnumed.122.263892; DOI: https://doi.org/10.2967/jnumed.122.263892
  • You have access
    Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT for characterization of solid renal masses
    Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa R Schmidt, Robert S Figenshau, Farrokh Dehdashti and Richard L Wahl
    Journal of Nuclear Medicine June 30, 2022, jnumed.122.264329; DOI: https://doi.org/10.2967/jnumed.122.264329
  • You have access
    The Impact of Peptide Amount on Tumor Uptake to Assess PSMA Receptor Saturation on 68Ga-PSMA-11 PET/CT in Primary Prostate Cancer Patients
    Hinke Siebinga, Judith olde Heuvel, Erik-Jan Rijkhorst, Jeroen J.M.A. Hendrikx and Berlinda J. de Wit - van der Veen
    Journal of Nuclear Medicine June 9, 2022, jnumed.122.264101; DOI: https://doi.org/10.2967/jnumed.122.264101
  • Pretherapeutic Comparative Dosimetry of <sup>177</sup>Lu-rhPSMA-7.3 and <sup>177</sup>Lu-PSMA I&amp;T in Patients with Metastatic Castration-Resistant Prostate Cancer
    You have access
    Pretherapeutic Comparative Dosimetry of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
    Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria and Matthias Eiber
    Journal of Nuclear Medicine June 1, 2022, 63 (6) 833-839; DOI: https://doi.org/10.2967/jnumed.121.262671
  • You have access
    Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice.
    Chloé S Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R Sautois and Nadia Withofs
    Journal of Nuclear Medicine May 12, 2022, jnumed.121.263611; DOI: https://doi.org/10.2967/jnumed.121.263611
  • You have access
    Correlation of 68Ga-RM2 PET with Post-Surgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
    Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 12, 2022, jnumed.122.263971; DOI: https://doi.org/10.2967/jnumed.122.263971
  • You have access
    68Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment
    Farshad Moradi, Heying Duan, Hong Song, Guido A Davidzon, Benjamin I Chung, Alan E C Thong, Andreas M Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
    Journal of Nuclear Medicine May 5, 2022, jnumed.122.263897; DOI: https://doi.org/10.2967/jnumed.122.263897
  • 
    A Comparison of <sup>18</sup>F-DCFPyL, <sup>18</sup>F-NaF, and <sup>18</sup>F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
    You have access
    A Comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer
    Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, Joanna J. Shih, Baris Turkbey, Maxime Blain, Ethan Bergvall, Frank Lin, Stephen Adler, Ilhan Lim, Ravi A. Madan, Fatima Karzai, James L. Gulley, William L. Dahut, Bradford J. Wood, Richard Chang, Elliot Levy, Peter L. Choyke and Liza Lindenberg
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 735-741; DOI: https://doi.org/10.2967/jnumed.121.262371
  • Detection of Additional Primary Neoplasms on <sup>18</sup>F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
    You have access
    Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer
    Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti and Richard L. Wahl
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 713-719; DOI: https://doi.org/10.2967/jnumed.121.262647
  • You have access
    Outcome of patients with PSMA-PET/CT screen failure by VISION criteria and treated with 177Lu-PSMA therapy: a multicenter retrospective analysis
    Masatoshi Hotta, Andrei Gafita, Johannes Czernin and Jeremie Calais
    Journal of Nuclear Medicine April 14, 2022, jnumed.121.263441; DOI: https://doi.org/10.2967/jnumed.121.263441

Pages

  • Next
  • 1
  • 2
  • 3
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire